Swept-source optical coherence tomography objective composite activity score for uveitis.


Journal

Acta ophthalmologica
ISSN: 1755-3768
Titre abrégé: Acta Ophthalmol
Pays: England
ID NLM: 101468102

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 01 12 2020
received: 29 03 2020
accepted: 07 12 2020
pubmed: 10 1 2021
medline: 18 1 2022
entrez: 9 1 2021
Statut: ppublish

Résumé

To develop an objective intraocular inflammation composite score. Cross-sectional study. Non-invasive image acquisition and processing were conducted from April 2017 to April 2019. Inflammation-grade stratified eyes from patients with active, inactive uveitis and healthy controls were recruited. After clinical assessment, four anterior and posterior segment image acquisition protocols per eye, using swept-source optical coherence tomography (SS-OCT), were performed at inclusion. Eight imaging biomarkers in three domains: anterior, intermediate and posterior were studied. They were ranked and selected by discriminatory power and correlation with clinical scores. A final SS-OCT-derived composite uveitis activity score (SS-UAS) was developed through multiple linear regression. We studied 224 eyes with uveitis (165 active and 59 inactive) from 165 patients (mean age 46.6 SD 15.5 years; 55.3% women) and 38 eyes from 19 healthy controls (mean age 43.6 SD 17.1; 47% women). The selected SS-OCT-derived biomarkers to build the final score were anterior chamber hyper-reflective dots (anterior), high-definition relative vitreous intensity (intermediate) and the averaged thickened retinal index (posterior). Swept-source (SS)-UAS was highly discriminant between active and inactive, and between active and healthy eyes (means 2.06 SD 1.86, 0.93 SD 0.44, and 0.96 SD 0.38, respectively, both p -, Mann-Whitney U). Construct validity (Cronbach's alpha = 0.7), internal consistency, criterion validity and reliability (concordance correlation coefficient intra-rater = 0.99, 95% CI: 0.98-0.99; inter-rater = 0.98, 95% CI: 0.96-0.99) were favourable. Global intraocular inflammation can potentially be staged and scored objectively, continuously, consistently and in a valid manner through the combined processing of SS-OCT scans.

Identifiants

pubmed: 33421360
doi: 10.1111/aos.14739
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

756-764

Subventions

Organisme : NEI NIH HHS
ID : P30 EY010572
Pays : United States
Organisme : Instituto de Salud Carlos III
ID : PI17/00316
Organisme : AbbVie Biotherapeutics
ID : IIS 11329 (SA-000805)

Informations de copyright

© 2021 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Références

Agarwal A, Ashokkumar D, Jacob S, Agarwal A & Saravanan Y (2009): High-speed optical coherence tomography for imaging anterior chamber inflammatory reaction in uveitis: clinical correlation and grading. Am J Ophthalmol 147: 413-416.e3.
Asrani S, Moore DB & Jaffe GJ (2014): Paradoxical changes of retinal nerve fiber layer thickness in uveitic glaucoma. JAMA Ophthalmol 132: 877-880.
Baghdasaryan E, Tepelus TC, Marion KM, Huang J, Huang P, Sadda SR & Lee OL (2019): Analysis of ocular inflammation in anterior chamber-involving uveitis using swept-source anterior segment OCT. Int Ophthalmol 39: 1793-1801.
Bloch-Michel E & Nussenblatt RB (1987): International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol 103: 234-235.
Cunningham ET Jr, Hubbard LD, Danis RP & Holland GN (2011): Proportionate topographic areas of retinal zones 1, 2, and 3 for use in describing infectious retinitis. Arch Ophthalmol 129: 1507-1508.
Dastiridou AI, Bousquet E, Kuehlewein L, Tepelus T, Monnet D, Salah S, Brezin A & Sadda SR (2017): Choroidal imaging with swept-source optical coherence tomography in patients with birdshot chorioretinopathy: choroidal reflectivity and thickness. Ophthalmology 124: 1186-1195.
Davis JL, Madow B, Cornett J, Stratton R, Hess D, Porciatti V & Feuer WJ (2010): Scale for photographic grading of vitreous haze in uveitis. Am J Ophthalmol 150: 637-641.e1.
Denniston AK, Holland GN, Kidess A, Nussenblatt RB, Okada AA, Rosenbaum JT & Dick AD (2015): Heterogeneity of primary outcome measures used in clinical trials of treatments for intermediate, posterior, and panuveitis. Orphanet J Rare Dis 10: 97.
Denniston AK, Keane PA & Srivastava SK (2017): Biomarkers and surrogate endpoints in uveitis: the impact of quantitative imaging. Invest Ophthalmol Vis Sci 58: BIO131-BIO140.
Durrani OM, Tehrani NN, Marr JE, Moradi P, Stavrou P & Murray PI (2004): Degree, duration, and causes of visual loss in uveitis. Br J Ophthalmol 88: 1159-1162.
Holland GN, Buhles WC Jr, Mastre B & Kaplan HJ (1989): A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group. Arch Ophthalmol 107: 1759-1766.
Hornbeak DM, Payal A, Pistilli M et al. (2014): Interobserver agreement in clinical grading of vitreous haze using alternative grading scales. Ophthalmology 121: 1643-1648.
Igbre AO, Rico MC & Garg SJ (2014): High-speed optical coherence tomography as a reliable adjuvant tool to grade ocular anterior chamber inflammation. Retina 34: 504-508.
Invernizzi A, Marchi S, Aldigeri R et al. (2017): Objective quantification of anterior chamber inflammation: measuring cells and flare by anterior segment optical coherence tomography. Ophthalmology 124: 1670-1677.
Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group (2005): Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140: 509-516.
Keane PA, Balaskas K, Sim DA, Aman K, Denniston AK, Aslam T; And For The Equator Study Group (2015): Automated analysis of vitreous inflammation using spectral-domain optical coherence tomography. Transl Vis Sci Technol 4: 4.
Keane PA, Karampelas M, Sim DA et al. (2014): Objective measurement of vitreous inflammation using optical coherence tomography. Ophthalmology 121: 1706-1714.
Kempen JH, Ganesh SK, Sangwan VS & Rathinam SR (2008): Interobserver agreement in grading activity and site of inflammation in eyes of patients with uveitis. Am J Ophthalmol 146: 813-818.e1.
Khairallah M (2010): Are the Standardization of the Uveitis Nomenclature (SUN) Working Group criteria for codifying the site of inflammation appropriate for all uveitis problems? Limitations of the SUN Working Group classification. Ocul Immunol Inflamm 18: 2-4.
Knickelbein JE, Tucker W, Kodati S, Akanda M & Sen HN (2018): Non-invasive method of monitoring retinal vasculitis in patients with birdshot chorioretinopathy using optical coherence tomography. Br J Ophthalmol 102: 815-820.
Li Y, Lowder C, Zhang X & Huang D (2013): Anterior chamber cell grading by optical coherence tomography. Invest Ophthalmol Vis Sci 54: 258-265.
Madow B, Galor A, Feuer WJ, Altaweel MM & Davis JL (2011): Validation of a photographic vitreous haze grading technique for clinical trials in uveitis. Am J Ophthalmol 152: 170-176.e1.
Moore DB, Jaffe GJ & Asrani S (2015): Retinal nerve fiber layer thickness measurements: uveitis, a major confounding factor. Ophthalmology 122: 511-517.
Nussenblatt RB (1990): The natural history of uveitis. Int Ophthalmol 14: 303-308.
Nussenblatt RB, Palestine AG, Chan CC & Roberge F (1985): Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92: 467-471.
Pato E, Martin-Martinez MA, Castelló A et al. (2017): Development of an activity disease score in patients with uveitis (UVEDAI). Rheumatol Int 37: 647-656.
Potsaid B, Baumann B, Huang D, Barry S, Cable AE, Schuman JS, Duker JS & Fujimoto JG (2010): Ultrahigh speed 1050nm swept source/Fourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second. Opt Express 18: 20029-20048.
Rothova A, Suttorp-van Schulten MS, Frits Treffers W & Kijlstra A (1996): Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80: 332-336.
Saito M, Barbazetto IA & Spaide RF (2013): Intravitreal cellular infiltrate imaged as punctate spots by spectral-domain optical coherence tomography in eyes with posterior segment inflammatory disease. Retina 33: 559-565.
Sharma S, Lowder CY, Vasanji A, Baynes K, Kaiser PK & Srivastava SK (2015): Automated analysis of anterior chamber inflammation by spectral-domain optical coherence tomography. Ophthalmology 122: 1464-1470.
Singh SR, Vupparaboina KK, Goud A, Dansingani KK & Chhablani J (2019): Choroidal imaging biomarkers. Surv Ophthalmol 64: 312-333.
Sparrow JM, Taylor H, Qureshi K, Smith R, Birnie K, Johnston RL; UK EPR User Group (2012): The Cataract National Dataset electronic multi-centre audit of 55,567 operations: risk indicators for monocular visual acuity outcomes. Eye (Lond) 26: 821-826.
Thomas AS, Hatef AL, Stinnett SS, Keenan RT & Jaffe GJ (2019): Perivascular thickening on optical coherence tomography as a marker of inflammation in birdshot retinochoroiditis. Retina 39: 956-963.
Tugal-Tutkun I, Herbort CP, Khairallah M; Angiography Scoring for Uveitis Working Group (ASUWOG) (2010a): Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 30: 539-552.
Tugal-Tutkun I, Herbort CP, Khairallah M & Mantovani A (2010b): Interobserver agreement in scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation. Ocul Immunol Inflamm 18: 385-389.
U.S. Department of Health and Human Services Food and Drug Administration Guidance for Industry Patient-Reported Outcome Measures (2009):Use in medical product development to support labeling claims. Available at https://www.fda.gov/media/77832/download (Accessed on 16 February 2020).
Zarranz-Ventura J, Keane PA, Sim DA et al. (2016): Evaluation of objective vitritis grading method using optical coherence tomography: influence of Phakic status and previous vitrectomy. Am J Ophthalmol 161: 172-180.e804.

Auteurs

Victor Llorenç (V)

Clínic Institute of Ophthalmology (ICOF), Clínic Hospital of Barcelona, Barcelona, Spain.
Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Clínic Hospital of Barcelona, Barcelona, Spain.

Alba R Serrano (AR)

Clínic Institute of Ophthalmology (ICOF), Clínic Hospital of Barcelona, Barcelona, Spain.

Marina Mesquida (M)

Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Clínic Hospital of Barcelona, Barcelona, Spain.

Phoebe Lin (P)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Cristina Esquinas (C)

Vall d'Hebron Research Institute, Autonomous University of Barcelona, Barcelona, Spain.

Maite Sainz-de-la-Maza (M)

Clínic Institute of Ophthalmology (ICOF), Clínic Hospital of Barcelona, Barcelona, Spain.
Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Clínic Hospital of Barcelona, Barcelona, Spain.

Christina Metea (C)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Anna Bosch (A)

Advanced Optical Microscopy Unit. School of Medicine, University of Barcelona, Barcelona, Spain.

Maria Calvo (M)

Advanced Optical Microscopy Unit. School of Medicine, University of Barcelona, Barcelona, Spain.

Ariel Balter (A)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Yukiko Nakamura (Y)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Blanca Molins (B)

Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Clínic Hospital of Barcelona, Barcelona, Spain.

Carmen Alba (C)

Clínic Institute of Ophthalmology (ICOF), Clínic Hospital of Barcelona, Barcelona, Spain.

Eric Suhler (E)

Casey Eye Institute, Oregon Health & Science University, Portland, OR, USA.

Alfredo Adán (A)

Clínic Institute of Ophthalmology (ICOF), Clínic Hospital of Barcelona, Barcelona, Spain.
Biomedical Research Institute August Pi i Sunyer (IDIBAPS), Clínic Hospital of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH